Magic mushrooms in palliative care: Clinicians are keen but ill-equipped

Once relegated to the counterculture, psilocybin—the psychoactive compound in "magic mushrooms"—has been receiving renewed scientific attention. A growing body of research points to its potential for treating depression, addiction and end-of-life distress, prompting several countries to loosen regulations and greenlight clinical use.

Read it at Medical Xpress ↗

← Front page